Publication | Open Access
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
52
Citations
34
References
2017
Year
Twice-daily Intranasal OxytocinPsychiatryPsychotic DisorderPsychopharmacologySchizophrenia12-Week RandomizedSocial SciencesNeuroscienceMedicineSocial Cognitive DeficitsPsychopathology
| Year | Citations | |
|---|---|---|
Page 1
Page 1